REVIVA PHARMACEUTCLS HLDGS I

Historical 13F Holders

Symbol
RVPH
CUSIP
76152G209
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 76152G209 since 12/18/2024, largest first.

Filer % of Class Filed
Integrated Core Strategies (US) LLC 13G/A
8.2% 8/3/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
CVI Investments, Inc. 13G/A
4.9% 5/15/2026
Event 3/31/2026
Parag Saxena 13D/A 2.8% 3/24/2026
Event 3/20/2026
Barclays PLC 13G/A 0% 8/13/2026
Event 6/30/2026
UBS Group AG 13G/A 0% 7/31/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 1.00 $0
2026 Q2 5 7.73 k $3.67 k
2026 Q1 37 2.92 M $2.13 M
2025 Q4 1 129 k $44.0 k